WHITBY GROUP PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: B82017 | WHITBY, YO21 1SD
Showing results 101-150 of 740
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Digoxin | 839 | 21.8K | £1.6K | +121.7% ▲ |
| Combined ethinylestradiol 30mcg | 805 | 68.9K | £5.7K | +189.8% ▲ |
| Doxycycline hyclate | 800 | 9,477 | £940 | +56.1% ▲ |
| 796 | 111.7K | £4.1K | +187.9% ▲ | |
| Sodium valproate | 788 | 131.8K | £13.5K | +147.7% ▲ |
| Loperamide hydrochloride | 772 | 56.3K | £2.9K | +231.5% ▲ |
| Warfarin sodium | 771 | 34.8K | £1.2K | +63.5% ▲ |
| Methotrexate | 759 | 17.6K | £7.6K | +133.2% ▲ |
| Carbamazepine | 743 | 80.4K | £4.0K | +150.4% ▲ |
| Perindopril erbumine | 739 | 24.4K | £2.0K | +39.2% ▲ |
| Insulin aspart | 735 | 4,891 | £30.7K | +93.0% ▲ |
| Oxycodone hydrochloride | 721 | 71.9K | £9.7K | +181.7% ▲ |
| Solifenacin | 715 | 22.1K | £846 | +49.8% ▲ |
| Sacubitril/valsartan | 697 | 35.1K | £55.7K | +191.1% ▲ |
| Medroxyprogesterone acetate | 696 | 718 | £3.9K | +476.5% ▲ |
| Tirzepatide | 691 | 700 | £65.5K | +255.8% ▲ |
| Sumatriptan succinate | 689 | 6,512 | £8.4K | +94.6% ▲ |
| Estradiol | 674 | 16.3K | £9.3K | +149.8% ▲ |
| Eplerenone | 668 | 17.0K | £2.1K | +151.9% ▲ |
| Mirabegron | 667 | 18.0K | £16.5K | +66.0% ▲ |
| Dihydrocodeine tartrate | 663 | 50.4K | £3.9K | +239.4% ▲ |
| 654 | 661 | £29.0K | +110.5% ▲ | |
| 654 | 113.6K | £6.9K | +543.9% ▲ | |
| Quetiapine | 636 | 22.7K | £11.0K | +2.2% ▲ |
| Carbomer 940/980 | 630 | 9,900 | £2.3K | +313.7% ▲ |
| Nitrofurantoin | 629 | 9,808 | £2.5K | +31.8% ▲ |
| Measles, mumps and rubella vaccine | 627 | 627 | £6.1K | +3,532.9% ▲ |
| Lactulose | 615 | 370.5K | £3.4K | +86.8% ▲ |
| Estriol | 601 | 10.6K | £6.5K | +182.4% ▲ |
| Olanzapine | 598 | 16.4K | £1.8K | +61.4% ▲ |
| Diclofenac diethyl | 594 | 69.6K | £4.3K | +67.3% ▲ |
| Memantine hydrochloride | 569 | 11.8K | £1.4K | +72.2% ▲ |
| Flucloxacillin sodium | 569 | 23.9K | £1.6K | +26.5% ▲ |
| Hyoscine butylbromide | 562 | 40.5K | £3.0K | +141.1% ▲ |
| Aripiprazole | 553 | 17.0K | £2.8K | +117.3% ▲ |
| Betahistine hydrochloride | 543 | 43.8K | £1.4K | +127.4% ▲ |
| Bimatoprost | 535 | 4,032 | £3.8K | +259.9% ▲ |
| Paroxetine hydrochloride | 534 | 17.4K | £1.2K | +186.2% ▲ |
| Nicorandil | 532 | 29.6K | £4.2K | +269.6% ▲ |
| Co-beneldopa (Benserazide/levodopa) | 521 | 74.5K | £4.5K | +244.6% ▲ |
| Glyceryl trinitrate | 518 | 1,179 | £1.4K | +119.0% ▲ |
| 510 | 1,638 | £372 | +1,330.2% ▲ | |
| 508 | 5,446 | £2.0K | +103.6% ▲ | |
| Loratadine | 502 | 19.2K | £417 | +140.2% ▲ |
| Escitalopram | 496 | 13.7K | £834 | +74.3% ▲ |
| Docusate sodium | 486 | 42.8K | £3.0K | +31.1% ▲ |
| Nifedipine | 475 | 24.6K | £5.1K | +153.5% ▲ |
| Mesalazine (Systemic) | 471 | 49.3K | £20.8K | +96.6% ▲ |
| Biphasic isophane insulin | 464 | 2,759 | £11.6K | +315.9% ▲ |
| Tolterodine | 462 | 23.4K | £1.7K | +210.8% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.